OVERVIEW OF THE CASE AND ONGOING INVESTIGATION
Stueve Siegel Hanson LLP is investigating several individual cases involving life-threatening adverse reactions and death in patients taking the prescription drug Tussionex.
Tussionex Extended-Release Suspension is a cough-suppressant/antihistamine combination prescribed to treat coughs and upper-respiratory symptoms of colds and allergies. The FDA just recently issued a public health advisory to alert patients that death and life-threatening side effects have been reported in patients using Tussionex. The reports indicate that doctors have inappropriately prescribed Tussionex for patients less than 6 years old and at doses more frequent than every 12 hours.
If you or your child have suffered adverse reactions from the use of Tussionex, or you would like more information about these issues, please contact Todd Hilton at 1-800-714-0360 or email him at hilton@stuevesiegel.com.
Why Stueve Siegel Hanson?
Stueve Siegel Hanson is a national litigation firm specializing in complex business litigation, securities litigation, and consumer class actions. We have obtained substantial results for our clients in all types of litigation around the country, and have collectively been honored with dozens of awards and designations, for both our trial successes, and case results.
